« Previous
Next »
Journal of Diabetes and Its Complications
Volume 18, Issue 6
, Pages
336-342
, November 2004
Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860)
To access this article, please choose from the options below
PII: S1056-8727(04)00037-6
doi: 10.1016/j.diacomp.2004.04.003
© 2004 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Diabetes and Its Complications
Volume 18, Issue 6
, Pages
336-342
, November 2004
